HIV Treatment Adherence Research (R01)

The summary for the HIV Treatment Adherence Research (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, the government agency offering the grant, funding award amounts, and important deadlines. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.

Federal Grant Title:	HIV Treatment Adherence Research (R01)
CFDA Number:	93.242
CFDA Description:	Mental Health Research Grants
Federal Agency Name:	National Institutes of Health
Category of Funding Activity:	Education Health
Category Explanation:	Information not provided
Opportunity Category:	Discretionary
Funding Opportunity Number:	PA-07-338
Document Type:	Modification to Previous Grants Notice
Funding Instrument Type:	Grant
Posted Date:	Mar 27, 2007
Creation Date:	Nov 27, 2009
Original Closing Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
Current Closing Date for Applications:	Jan 07, 2010 Multiple Receipt Dates - See Link to Full Announcement for details.
Archive Date:	Feb 07, 2010
Expected Number of Awards:	Information not provided
Estimated Total Program Funding:	Information not provided
Federal Grant Award Ceiling:	Information not provided
Federal Grant Award Floor:	Information not provided
Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply.
Grant Description: -Purpose. This funding opportunity announcement (FOA) issued by the National Institute of Mental Health, National Institute on Drug Abuse, and National Institute of Nursing Research invites grant applications from applicant organizations to advance scientific research and intervention regarding HIV treatment adherence. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with FOAs of similar scientific scope, PA-07-339 which solicits applications under the Small Research Grant (R03) mechanism; PA-07-340, which solicits applications under the Exploratory/Developmental (R21) mechanism; and PAR-07-341, which solicits applications under the Exploratory Grants for Mental Health Interventions and Services (R34) mechanism. Please note that the participating organizations vary across this set of FOAs. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pa-07-338.html
Grant Announcement Contact: NIH OER Webmaster FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Novel NeuroAIDS Therapeutics: Integrated Preclinical/Clinical Program (P01); • Seek, Test, Treat, and Retain: Addressing HIV among Vulnerable Populations (R01); • Opportunity RFA-AI-10-022; • Microbicide Innovation Program (MIP VI) (R21/R33); • Development and Translation of Medical Technologies that Reduce Health Disparities (SBIR [R43/R44]); • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R42]); • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44]); • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44]); • Pharmacologic Agents and Drugs for Mental Disorders (STTR [R41/R42]); • Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Screening Cent...